HeyJaredVITALS
VITALS, the pulse of Georgia life sciences, brings together the leaders, the thinkers, the movers, and shakers who are putting Georgia firmly in a leadership position for what is widely known as "the biology century."These closely curated conversations are led by the…
- Indexed episodes, last 90 days
- 3
- Latest publication
- Sep 8, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 28, 2026
Latest episodes
GLS Vitals Episode 13 - Turning Biotech Uncertainty Into a Competitive Advantage (opens the original)
Read excerpt
Uncertainty isn’t going away. From AI and geopolitical shifts to supply chain disruption and changing healthcare policy, today’s life sciences leaders are navigating a landscape where the only constant is change.But what if uncertainty isn’t just something to manage—it’s something you can use to your advantage? In the latest episode of Vitals, Gary Lynch, Founder & CEO of The Risk Project and author of Uncertainty Advantage: Single Point of Failure or Opportunity? , shares insights from decades
GLS Vitals Episode 12 - Moving Quickly with a Long-Term Strategy: Building a Scrappy Rare Disease Company (opens the original)
Read excerpt
WELCOME TO VITALS, THE PULSE OF GEORGIA LIFE SCIENCES In this episode Georgia Life Sciences President & CEO, Maria Thacker Goethe, sits down with Dave Penake, CEO of Saol Therapeutics and Chair of Georgia Life Sciences, for a conversation about leadership, biotech growth, rare disease innovation, and the future of Georgia’s life sciences ecosystem.Drawing on a career that has taken him from semiconductor manufacturing to biotech hubs in Boston and the San Francisco Bay Area—and ultimately to Atl
GLS Vitals Episode 11 - Building Tomorrow: Biotech, Innovation, Talent & Growth (opens the original)
Read excerpt
WELCOME TO VITALS, THE PULSE OF GEORGIA LIFE SCIENCES In this episode of Vitals: Georgia's Life Sciences Podcast, Georgia Life Sciences President & CEO Maria Thacker Goethe sits down with Helen Tarlatin, Director of Employee & Community Engagement at UCB, to discuss one of the most significant life sciences investments in Georgia's history. Fresh off UCB's announcement of its $2 billion biologics manufacturing facility in Gwinnett County, Helen shares why Georgia emerged as the ideal location, w
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.